ArticleFrontiers in public health2025
State of the art in biosafety at the European National Reference Laboratories for Transmissible Spongiform Encephalopathies.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Laboratory technicians handling material containing or potentially infected with prions are exposed to the occupational risk of contracting infectious forms of Creutzfeldt-Jakob disease. The occurrence of three fatalities among laboratory personnel with a history of occupational exposure to bovine spongiform encephalopathy has highlighted the need for greater attention to the correct implementation of biosafety procedures in laboratories that handle prions. Methods: The European Reference Laboratory for Transmissible Spongiform Encephalopathies (EURL-TSE) carried out a survey to review biosafety procedures currently adopted by the 31 National Reference Laboratories for TSEs (NRLs), stimulate discussion among laboratory directors, and define future actions aimed at reducing the risk of occupational exposure among laboratory personnel. Results: The survey showed that 83.9% of laboratories adhered to TSE-specific biosafety guidelines, and 61.3% had conducted a biosafety risk assessment, while the biosafety level of the facilities had been determined in 93.5% of cases. In addition, 83.9% reported implementing staff biosafety training protocols, and 77.4% had procedures addressing the risk associated with sharp or pointed tools. Most laboratories had established biosafety procedures for ELISA and western blot assays, whereas fewer had protocols for pathology and immunohistochemistry. Among the three facilities performing experimental inoculations, only two indicated having specific biosafety measures in place. Discussion: Despite the overall positive results, the survey showed that biosafety procedures are applied heterogeneously across the NRLs. The EURL-TSE will further encourage the full implementation of specific biosafety procedures to address the gaps identified by the survey. The EURL-TSE has created a digital repository of guidelines and bibliographical sources on the subject. It also initiated biannual virtual meetings to discuss critical issues emerged from the survey and to encourage the mutual exchange of experiences and good practices between NRLs Directors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.